These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21872257

  • 1. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.
    Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T.
    J Chromatogr A; 2011 Oct 21; 1218(42):7713-22. PubMed ID: 21872257
    [Abstract] [Full Text] [Related]

  • 2. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H, Xu J, McKeel DW, Han X.
    Cell Mol Biol (Noisy-le-grand); 2003 Jul 21; 49(5):809-18. PubMed ID: 14528918
    [Abstract] [Full Text] [Related]

  • 3. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 4. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S, Poirier J, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R.
    Neurobiol Aging; 2006 Feb 01; 27(2):199-210. PubMed ID: 16399207
    [Abstract] [Full Text] [Related]

  • 5. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT, Trojanowski JQ, Lee VM.
    Lab Invest; 1992 Feb 01; 66(2):212-22. PubMed ID: 1735956
    [Abstract] [Full Text] [Related]

  • 6. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
    Wang L, Sato H, Zhao S, Tooyama I.
    Neurosci Lett; 2010 Sep 13; 481(3):164-7. PubMed ID: 20599473
    [Abstract] [Full Text] [Related]

  • 7. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 8. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
    Grimm MO, Kuchenbecker J, Rothhaar TL, Grösgen S, Hundsdörfer B, Burg VK, Friess P, Müller U, Grimm HS, Riemenschneider M, Hartmann T.
    J Neurochem; 2011 Mar 03; 116(5):916-25. PubMed ID: 21214572
    [Abstract] [Full Text] [Related]

  • 9. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA, Nafe R, Schlote W.
    Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153
    [Abstract] [Full Text] [Related]

  • 10. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T, Mishra M, Akatsu H, Tani Y, Miyauchi T, Yamamoto T, Kosaka K, Nagai Y, Sawada T, Heese K.
    Eur J Clin Invest; 2006 Nov 05; 36(11):820-30. PubMed ID: 17032350
    [Abstract] [Full Text] [Related]

  • 11. Fibre diffraction of hair can provide a screening test for Alzheimer's disease: a human and animal model study.
    James VJ, Richardson JC, Robertson TA, Papadimitriou JM, Dutton NS, Maley MA, Berstein LM, Lantseva OE, Martins RN.
    Med Sci Monit; 2005 Feb 05; 11(2):CR53-7. PubMed ID: 15668631
    [Abstract] [Full Text] [Related]

  • 12. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J, Lintner F, Jellinger KA.
    Acta Neuropathol; 2004 Apr 05; 107(4):283-91. PubMed ID: 14986026
    [Abstract] [Full Text] [Related]

  • 13. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease.
    Mulder C, Wahlund LO, Teerlink T, Blomberg M, Veerhuis R, van Kamp GJ, Scheltens P, Scheffer PG.
    J Neural Transm (Vienna); 2003 Aug 05; 110(8):949-55. PubMed ID: 12898349
    [Abstract] [Full Text] [Related]

  • 14. High-throughput quantification of Alzheimer's disease pathological markers in the post-mortem human brain.
    Byrne UT, Ross JM, Faull RL, Dragunow M.
    J Neurosci Methods; 2009 Jan 30; 176(2):298-309. PubMed ID: 18835409
    [Abstract] [Full Text] [Related]

  • 15. Amyloid-beta aggregation.
    Finder VH, Glockshuber R.
    Neurodegener Dis; 2007 Jan 30; 4(1):13-27. PubMed ID: 17429215
    [Abstract] [Full Text] [Related]

  • 16. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM.
    Acta Neuropathol; 2006 Aug 30; 112(2):163-74. PubMed ID: 16865398
    [Abstract] [Full Text] [Related]

  • 17. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA.
    Neurobiol Aging; 2006 Nov 30; 27(11):1564-76. PubMed ID: 16271804
    [Abstract] [Full Text] [Related]

  • 18. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
    Kawabata S, Higgins GA, Gordon JW.
    Nature; 1991 Dec 12; 354(6353):476-8. PubMed ID: 1793460
    [Abstract] [Full Text] [Related]

  • 19. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA, Leach KL, Trojanowski JQ, Lee VM.
    Lab Invest; 1991 Jan 12; 64(1):35-44. PubMed ID: 1990207
    [Abstract] [Full Text] [Related]

  • 20. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.
    Yuki D, Sugiura Y, Zaima N, Akatsu H, Takei S, Yao I, Maesako M, Kinoshita A, Yamamoto T, Kon R, Sugiyama K, Setou M.
    Sci Rep; 2014 Nov 20; 4():7130. PubMed ID: 25410733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.